Drug Profile
Research programme: fibroblast growth factors - Metacrine/Novo Nordisk
Alternative Names: FGF-1 variants - Metacrine/Novo NordiskLatest Information Update: 28 Sep 2021
Price :
$50
*
At a glance
- Originator Metacrine
- Developer Metacrine; Novo Nordisk
- Class Antihyperglycaemics; Fibroblast growth factors; Proteins
- Mechanism of Action Fibroblast growth factor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diabetes mellitus